nodes	percent_of_prediction	percent_of_DWPC	metapath
Choline—osteoarthritis—Methylprednisolone—ankylosing spondylitis	0.489	0.5	CpDpCtD
Choline—osteoarthritis—Prednisone—ankylosing spondylitis	0.489	0.5	CpDpCtD
Choline—PLD1—cartilage tissue—ankylosing spondylitis	0.00806	0.451	CbGeAlD
Choline—SLC44A3—tendon—ankylosing spondylitis	0.0013	0.0728	CbGeAlD
Choline—CEPT1—tendon—ankylosing spondylitis	0.00117	0.0655	CbGeAlD
Choline—SLC44A2—tendon—ankylosing spondylitis	0.00113	0.063	CbGeAlD
Choline—CHKA—tendon—ankylosing spondylitis	0.0011	0.0613	CbGeAlD
Choline—SLC44A1—tendon—ankylosing spondylitis	0.00106	0.0593	CbGeAlD
Choline—PLD2—tendon—ankylosing spondylitis	0.00105	0.0589	CbGeAlD
Choline—PDE4D—tendon—ankylosing spondylitis	0.000658	0.0368	CbGeAlD
Choline—PDE3A—tendon—ankylosing spondylitis	0.000481	0.0269	CbGeAlD
Choline—ADORA1—tendon—ankylosing spondylitis	0.000469	0.0262	CbGeAlD
Choline—ACHE—tendon—ankylosing spondylitis	0.000466	0.0261	CbGeAlD
Choline—SLC22A4—tendon—ankylosing spondylitis	0.000356	0.0199	CbGeAlD
Choline—PDE4B—tendon—ankylosing spondylitis	0.000347	0.0194	CbGeAlD
Choline—SLC22A5—tendon—ankylosing spondylitis	0.000235	0.0132	CbGeAlD
Choline—SLC44A2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000109	0.0368	CbGpPWpGaD
Choline—SLC44A1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000109	0.0368	CbGpPWpGaD
Choline—SLC44A3—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000109	0.0368	CbGpPWpGaD
Choline—SLC44A4—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000109	0.0368	CbGpPWpGaD
Choline—SLC5A7—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000104	0.0353	CbGpPWpGaD
Choline—CHAT—SIDS Susceptibility Pathways—RUNX3—ankylosing spondylitis	9.02e-05	0.0306	CbGpPWpGaD
Choline—SLC5A7—Monoamine Transport—TNF—ankylosing spondylitis	8.54e-05	0.029	CbGpPWpGaD
Choline—PDE3B—Leptin signaling pathway—IL1RN—ankylosing spondylitis	6.45e-05	0.0219	CbGpPWpGaD
Choline—CHAT—SIDS Susceptibility Pathways—IL1RN—ankylosing spondylitis	6.22e-05	0.0211	CbGpPWpGaD
Choline—PDE4C—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	5.21e-05	0.0177	CbGpPWpGaD
Choline—PLD1—Immune System—KIR3DL1—ankylosing spondylitis	4.78e-05	0.0162	CbGpPWpGaD
Choline—ADORA2B—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	4.75e-05	0.0161	CbGpPWpGaD
Choline—PDE3B—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	4.61e-05	0.0156	CbGpPWpGaD
Choline—PLD2—Immune System—KIR3DL1—ankylosing spondylitis	4.6e-05	0.0156	CbGpPWpGaD
Choline—PDE4D—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	4.54e-05	0.0154	CbGpPWpGaD
Choline—CHAT—SIDS Susceptibility Pathways—IL1A—ankylosing spondylitis	4.48e-05	0.0152	CbGpPWpGaD
Choline—CHAT—SIDS Susceptibility Pathways—IL10—ankylosing spondylitis	4.45e-05	0.0151	CbGpPWpGaD
Choline—PLD2—Angiopoietin receptor Tie2-mediated signaling—TNF—ankylosing spondylitis	4.36e-05	0.0148	CbGpPWpGaD
Choline—PDE4A—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	4.32e-05	0.0146	CbGpPWpGaD
Choline—PLD1—Innate Immune System—CARD9—ankylosing spondylitis	4.31e-05	0.0146	CbGpPWpGaD
Choline—PDE3A—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	4.2e-05	0.0142	CbGpPWpGaD
Choline—PLD2—Innate Immune System—CARD9—ankylosing spondylitis	4.15e-05	0.0141	CbGpPWpGaD
Choline—PDE4B—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	3.99e-05	0.0135	CbGpPWpGaD
Choline—SLC22A4—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	3.85e-05	0.0131	CbGpPWpGaD
Choline—ADORA2A—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	3.12e-05	0.0106	CbGpPWpGaD
Choline—SLC22A3—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	2.91e-05	0.00984	CbGpPWpGaD
Choline—SLC22A5—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	2.9e-05	0.00981	CbGpPWpGaD
Choline—PLD1—Immune System—IL1R2—ankylosing spondylitis	2.9e-05	0.00981	CbGpPWpGaD
Choline—PCYT1B—Metabolism—B3GNT2—ankylosing spondylitis	2.87e-05	0.00974	CbGpPWpGaD
Choline—PLD2—Immune System—IL1R2—ankylosing spondylitis	2.79e-05	0.00944	CbGpPWpGaD
Choline—PLD1—Immune System—ERAP1—ankylosing spondylitis	2.74e-05	0.0093	CbGpPWpGaD
Choline—PLD1—Innate Immune System—HLA-C—ankylosing spondylitis	2.71e-05	0.00917	CbGpPWpGaD
Choline—PHOSPHO1—Metabolism—B3GNT2—ankylosing spondylitis	2.67e-05	0.00905	CbGpPWpGaD
Choline—ADORA2B—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	2.65e-05	0.00896	CbGpPWpGaD
Choline—PLD2—Immune System—ERAP1—ankylosing spondylitis	2.64e-05	0.00895	CbGpPWpGaD
Choline—PLD2—Innate Immune System—HLA-C—ankylosing spondylitis	2.61e-05	0.00883	CbGpPWpGaD
Choline—CEPT1—Metabolism—B3GNT2—ankylosing spondylitis	2.51e-05	0.00851	CbGpPWpGaD
Choline—CHKA—Metabolism—B3GNT2—ankylosing spondylitis	2.51e-05	0.00851	CbGpPWpGaD
Choline—PLD1—Immune System—CARD9—ankylosing spondylitis	2.51e-05	0.00851	CbGpPWpGaD
Choline—PLD2—Immune System—CARD9—ankylosing spondylitis	2.42e-05	0.00819	CbGpPWpGaD
Choline—CHKB—Metabolism—B3GNT2—ankylosing spondylitis	2.38e-05	0.00807	CbGpPWpGaD
Choline—ADORA2A—Monoamine Transport—TNF—ankylosing spondylitis	2.35e-05	0.00796	CbGpPWpGaD
Choline—SLC44A3—Metabolism—B3GNT2—ankylosing spondylitis	2.27e-05	0.0077	CbGpPWpGaD
Choline—SLC44A4—Metabolism—B3GNT2—ankylosing spondylitis	2.27e-05	0.0077	CbGpPWpGaD
Choline—SLC44A2—Metabolism—B3GNT2—ankylosing spondylitis	2.27e-05	0.0077	CbGpPWpGaD
Choline—SLC44A1—Metabolism—B3GNT2—ankylosing spondylitis	2.27e-05	0.0077	CbGpPWpGaD
Choline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	2.27e-05	0.00768	CbGpPWpGaD
Choline—ADORA1—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	2.25e-05	0.00762	CbGpPWpGaD
Choline—PCYT1A—Metabolism—B3GNT2—ankylosing spondylitis	2.02e-05	0.00686	CbGpPWpGaD
Choline—ADORA1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	1.93e-05	0.00653	CbGpPWpGaD
Choline—ACHE—Monoamine Transport—TNF—ankylosing spondylitis	1.88e-05	0.00636	CbGpPWpGaD
Choline—SLC22A2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	1.82e-05	0.00617	CbGpPWpGaD
Choline—ADORA2A—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	1.74e-05	0.00589	CbGpPWpGaD
Choline—ADORA2B—GPCR ligand binding—PTGER4—ankylosing spondylitis	1.73e-05	0.00585	CbGpPWpGaD
Choline—SLC22A1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	1.7e-05	0.00575	CbGpPWpGaD
Choline—CHAT—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	1.7e-05	0.00574	CbGpPWpGaD
Choline—PLD1—Metabolism—B3GNT2—ankylosing spondylitis	1.65e-05	0.00559	CbGpPWpGaD
Choline—PLD1—Innate Immune System—HLA-B—ankylosing spondylitis	1.6e-05	0.00542	CbGpPWpGaD
Choline—PLD2—Metabolism—B3GNT2—ankylosing spondylitis	1.59e-05	0.00538	CbGpPWpGaD
Choline—PLD1—Immune System—HLA-C—ankylosing spondylitis	1.58e-05	0.00534	CbGpPWpGaD
Choline—PLD2—Innate Immune System—HLA-B—ankylosing spondylitis	1.54e-05	0.00522	CbGpPWpGaD
Choline—CHAT—Metabolism—B3GNT2—ankylosing spondylitis	1.53e-05	0.0052	CbGpPWpGaD
Choline—PLD2—Immune System—HLA-C—ankylosing spondylitis	1.52e-05	0.00514	CbGpPWpGaD
Choline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	1.49e-05	0.00504	CbGpPWpGaD
Choline—ADORA1—GPCR ligand binding—PTGER4—ankylosing spondylitis	1.47e-05	0.00497	CbGpPWpGaD
Choline—PLD1—Innate Immune System—CRP—ankylosing spondylitis	1.41e-05	0.00479	CbGpPWpGaD
Choline—PLD1—Immune System—IL1RN—ankylosing spondylitis	1.37e-05	0.00464	CbGpPWpGaD
Choline—PLD2—Innate Immune System—CRP—ankylosing spondylitis	1.36e-05	0.00461	CbGpPWpGaD
Choline—PLD1—Innate Immune System—TLR4—ankylosing spondylitis	1.36e-05	0.0046	CbGpPWpGaD
Choline—PLD2—Immune System—IL1RN—ankylosing spondylitis	1.32e-05	0.00447	CbGpPWpGaD
Choline—PLD2—Innate Immune System—TLR4—ankylosing spondylitis	1.31e-05	0.00442	CbGpPWpGaD
Choline—PLD1—Immune System—CD79A—ankylosing spondylitis	1.2e-05	0.00407	CbGpPWpGaD
Choline—PLD2—Immune System—CD79A—ankylosing spondylitis	1.16e-05	0.00392	CbGpPWpGaD
Choline—ADORA2A—GPCR ligand binding—PTGER4—ankylosing spondylitis	1.13e-05	0.00384	CbGpPWpGaD
Choline—PDE4C—GPCR downstream signaling—PTGER4—ankylosing spondylitis	1.07e-05	0.00362	CbGpPWpGaD
Choline—PLD1—Immune System—IL1A—ankylosing spondylitis	9.86e-06	0.00334	CbGpPWpGaD
Choline—PLD1—Immune System—CD40LG—ankylosing spondylitis	9.8e-06	0.00332	CbGpPWpGaD
Choline—ADORA2B—GPCR downstream signaling—PTGER4—ankylosing spondylitis	9.75e-06	0.00331	CbGpPWpGaD
Choline—PDE4C—Signaling by GPCR—PTGER4—ankylosing spondylitis	9.71e-06	0.00329	CbGpPWpGaD
Choline—PLD2—Immune System—IL1A—ankylosing spondylitis	9.49e-06	0.00321	CbGpPWpGaD
Choline—PDE3B—GPCR downstream signaling—PTGER4—ankylosing spondylitis	9.46e-06	0.00321	CbGpPWpGaD
Choline—PLD2—Immune System—CD40LG—ankylosing spondylitis	9.43e-06	0.0032	CbGpPWpGaD
Choline—PLD1—Immune System—HLA-B—ankylosing spondylitis	9.32e-06	0.00316	CbGpPWpGaD
Choline—PDE4D—GPCR downstream signaling—PTGER4—ankylosing spondylitis	9.31e-06	0.00315	CbGpPWpGaD
Choline—ACHE—Metabolism of proteins—B3GNT2—ankylosing spondylitis	9.28e-06	0.00315	CbGpPWpGaD
Choline—PLD2—Immune System—HLA-B—ankylosing spondylitis	8.97e-06	0.00304	CbGpPWpGaD
Choline—ADORA2B—Signaling by GPCR—PTGER4—ankylosing spondylitis	8.86e-06	0.003	CbGpPWpGaD
Choline—PDE4A—GPCR downstream signaling—PTGER4—ankylosing spondylitis	8.86e-06	0.003	CbGpPWpGaD
Choline—PLD1—Immune System—HLA-A—ankylosing spondylitis	8.64e-06	0.00293	CbGpPWpGaD
Choline—PDE3A—GPCR downstream signaling—PTGER4—ankylosing spondylitis	8.62e-06	0.00292	CbGpPWpGaD
Choline—PDE3B—Signaling by GPCR—PTGER4—ankylosing spondylitis	8.59e-06	0.00291	CbGpPWpGaD
Choline—PDE4D—Signaling by GPCR—PTGER4—ankylosing spondylitis	8.45e-06	0.00286	CbGpPWpGaD
Choline—PLD2—Immune System—HLA-A—ankylosing spondylitis	8.31e-06	0.00282	CbGpPWpGaD
Choline—ADORA1—GPCR downstream signaling—PTGER4—ankylosing spondylitis	8.29e-06	0.00281	CbGpPWpGaD
Choline—BCHE—Metabolism of proteins—B3GNT2—ankylosing spondylitis	8.28e-06	0.00281	CbGpPWpGaD
Choline—PLD1—Immune System—CRP—ankylosing spondylitis	8.24e-06	0.00279	CbGpPWpGaD
Choline—PDE4B—GPCR downstream signaling—PTGER4—ankylosing spondylitis	8.2e-06	0.00278	CbGpPWpGaD
Choline—PDE4A—Signaling by GPCR—PTGER4—ankylosing spondylitis	8.04e-06	0.00273	CbGpPWpGaD
Choline—PLD2—Immune System—CRP—ankylosing spondylitis	7.93e-06	0.00269	CbGpPWpGaD
Choline—PLD1—Immune System—TLR4—ankylosing spondylitis	7.9e-06	0.00268	CbGpPWpGaD
Choline—PDE3A—Signaling by GPCR—PTGER4—ankylosing spondylitis	7.82e-06	0.00265	CbGpPWpGaD
Choline—PLD2—Immune System—TLR4—ankylosing spondylitis	7.6e-06	0.00258	CbGpPWpGaD
Choline—ADORA1—Signaling by GPCR—PTGER4—ankylosing spondylitis	7.53e-06	0.00255	CbGpPWpGaD
Choline—PDE4B—Signaling by GPCR—PTGER4—ankylosing spondylitis	7.44e-06	0.00252	CbGpPWpGaD
Choline—PDE4C—Signaling by GPCR—MMP3—ankylosing spondylitis	6.91e-06	0.00234	CbGpPWpGaD
Choline—ADORA2A—GPCR downstream signaling—PTGER4—ankylosing spondylitis	6.4e-06	0.00217	CbGpPWpGaD
Choline—ADORA2B—Signaling by GPCR—MMP3—ankylosing spondylitis	6.31e-06	0.00214	CbGpPWpGaD
Choline—PDE3B—Signaling by GPCR—MMP3—ankylosing spondylitis	6.12e-06	0.00207	CbGpPWpGaD
Choline—SLC22A3—Metabolism—B3GNT2—ankylosing spondylitis	6.08e-06	0.00206	CbGpPWpGaD
Choline—PDE4D—Signaling by GPCR—MMP3—ankylosing spondylitis	6.02e-06	0.00204	CbGpPWpGaD
Choline—ADORA2A—Signaling by GPCR—PTGER4—ankylosing spondylitis	5.82e-06	0.00197	CbGpPWpGaD
Choline—PDE4C—Signaling Pathways—PTGER4—ankylosing spondylitis	5.73e-06	0.00194	CbGpPWpGaD
Choline—PDE4A—Signaling by GPCR—MMP3—ankylosing spondylitis	5.73e-06	0.00194	CbGpPWpGaD
Choline—PDE3A—Signaling by GPCR—MMP3—ankylosing spondylitis	5.57e-06	0.00189	CbGpPWpGaD
Choline—ADORA1—Signaling by GPCR—MMP3—ankylosing spondylitis	5.36e-06	0.00182	CbGpPWpGaD
Choline—PDE4B—Signaling by GPCR—MMP3—ankylosing spondylitis	5.3e-06	0.0018	CbGpPWpGaD
Choline—ADORA2B—Signaling Pathways—PTGER4—ankylosing spondylitis	5.23e-06	0.00177	CbGpPWpGaD
Choline—PDE3B—Signaling Pathways—PTGER4—ankylosing spondylitis	5.07e-06	0.00172	CbGpPWpGaD
Choline—PDE4D—Signaling Pathways—PTGER4—ankylosing spondylitis	4.99e-06	0.00169	CbGpPWpGaD
Choline—ACHE—Metabolism—B3GNT2—ankylosing spondylitis	4.78e-06	0.00162	CbGpPWpGaD
Choline—PDE4A—Signaling Pathways—PTGER4—ankylosing spondylitis	4.75e-06	0.00161	CbGpPWpGaD
Choline—PDE3A—Signaling Pathways—PTGER4—ankylosing spondylitis	4.62e-06	0.00157	CbGpPWpGaD
Choline—ACHE—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	4.5e-06	0.00152	CbGpPWpGaD
Choline—ADORA1—Signaling Pathways—PTGER4—ankylosing spondylitis	4.45e-06	0.00151	CbGpPWpGaD
Choline—PDE4B—Signaling Pathways—PTGER4—ankylosing spondylitis	4.4e-06	0.00149	CbGpPWpGaD
Choline—BCHE—Metabolism—B3GNT2—ankylosing spondylitis	4.27e-06	0.00145	CbGpPWpGaD
Choline—ADORA2A—Signaling by GPCR—MMP3—ankylosing spondylitis	4.14e-06	0.0014	CbGpPWpGaD
Choline—PDE4C—Signaling Pathways—MMP3—ankylosing spondylitis	4.08e-06	0.00138	CbGpPWpGaD
Choline—SLC22A2—Metabolism—B3GNT2—ankylosing spondylitis	3.81e-06	0.00129	CbGpPWpGaD
Choline—ADORA2B—Signaling Pathways—MMP3—ankylosing spondylitis	3.73e-06	0.00126	CbGpPWpGaD
Choline—PDE3B—Signaling Pathways—MMP3—ankylosing spondylitis	3.61e-06	0.00122	CbGpPWpGaD
Choline—PDE4D—Signaling Pathways—MMP3—ankylosing spondylitis	3.55e-06	0.0012	CbGpPWpGaD
Choline—SLC22A1—Metabolism—B3GNT2—ankylosing spondylitis	3.55e-06	0.0012	CbGpPWpGaD
Choline—ADORA2A—Signaling Pathways—PTGER4—ankylosing spondylitis	3.44e-06	0.00116	CbGpPWpGaD
Choline—PDE4A—Signaling Pathways—MMP3—ankylosing spondylitis	3.38e-06	0.00115	CbGpPWpGaD
Choline—PDE3A—Signaling Pathways—MMP3—ankylosing spondylitis	3.29e-06	0.00112	CbGpPWpGaD
Choline—ADORA1—Signaling Pathways—MMP3—ankylosing spondylitis	3.17e-06	0.00107	CbGpPWpGaD
Choline—PDE4B—Signaling Pathways—MMP3—ankylosing spondylitis	3.13e-06	0.00106	CbGpPWpGaD
Choline—ADORA2A—Signaling Pathways—MMP3—ankylosing spondylitis	2.45e-06	0.000829	CbGpPWpGaD
